Browsing by Author "Pantovic, Maja (35085268700)"
Now showing 1 - 2 of 2
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Serum levels of interleukin-6 and tumor necrosis factor-alpha in exacerbation and remission phase of schizophrenia(2013) ;Dunjic-Kostic, Bojana (36760738400) ;Jasovic-Gasic, Miroslava (55945351100) ;Ivkovic, Maja (6603636580) ;Radonjic, Nevena V. (23390243000) ;Pantovic, Maja (35085268700) ;Damjanovic, Aleksandar (7004519596) ;Poznanovic, Sanja Totic (55545225800) ;Jovanovic, Aleksandar (58423375000) ;Nikolic, Tatjana (57235024600)Petronijevic, Natasa D. (6506911099)Background: The variations in proinflamatory cytokine levels have been associated with schizophrenia (SCH), duration of illness, psychopathology and treatment. The aim of the study was to investigate serum levels of interleukin-6 (IL-6) and tumor necrosis factoralpha (TNF-a) in schizophrenic patients during exacerbation and remission, and its association with course of illness and therapy. Subjects and methods: We measured serum levels of IL-6 and TNF-a in 43 schizophrenic patients in exacerbation and remission and compared them to 29 healthy controls, matched by sex, age, body mass index (BMI) and smoking habits. The severity of psychopathology was assessed using the Positive and Negative Syndrome Scale (PANSS). Results: There was no difference in levels of IL-6 and TNF-a in exacerbation compared to remission in schizophrenic patients. IL-6 was higher and TNF-a was lower in schizophrenic patients in both exacerbation and remission in comparison with healthy controls. TNF-a in exacerbation was in negative correlation with IL-6 in remission. No statistical significance was found between levels of cytokines and sex, age, BMI, smoking habits, antipsychotic medication, duration of treatment and duration of illness. IL-6 levels were in positive correlation with the age of onset and the duration of untreated psychosis. In schizophrenic patients on adjunctive treatment with mood stabilizers, TNF-a levels increased in remission. Conclusion: Our results suggest that the connection between schizophrenia, cytokines and medication is multifaceted, and not necessarily linear. Adjunct mood stabilizers not only ameliorate psychopathology, but might convey immunomodulatory effects as well. Further longitudinal studies could elucidate potential beneficial effect of combined therapy in treatment of SCH. © Medicinska naklada - Zagreb, Croatia. © Medicinska naklada - Zagreb, Croatia. - Some of the metrics are blocked by yourconsent settings
Publication The framework of family therapy in clinical practice and research in Serbia(2012) ;Pantovic, Maja (35085268700) ;Dunjic-Kostic, Bojana (36760738400) ;Ivkovic, Maja (6603636580) ;Damjanovic, Aleksandar (7004519596)Jovanovic, Aleksandar A. (58423375000)In the last two decades, Serbia has had to deal with multiple social and economic problems reflecting on society's demographics and seemed to weaken its core cell the family. The paper describes the framework of family therapy in clinical practice and research, within the recent transition of the Serbian family. Family therapy treatment in Serbia uses the systemic family therapy (SFT) approach, applied according to the standards of the European Association for Psychotherapy. A large number of professionals who practise in Serbia hold European qualifications, setting high standards in education, clinical practice, and research. Although SFT is also available in the private sector, the majority of patients are still treated in state institutions. Family therapy is often used for adults and adolescents with psychosis and addictions in psychiatric hospital settings. However, in counselling centres it is used for marital and relationship problems. Interestingly, family therapy has recently started to emerge as a more frequent tool in consultation-liaison, particularly psycho-oncology but also in correctional institutions. The clinical practice and research interests are interlinked with changes in social settings. © 2012 Institute of Psychiatry.
